ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 72 filers reported holding ALBIREO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $151,055 | +18.9% | 6,990 | +6.6% | 0.00% | – |
Q3 2022 | $127,000 | +0.8% | 6,556 | +3.5% | 0.00% | – |
Q2 2022 | $126,000 | -31.1% | 6,337 | +3.6% | 0.00% | – |
Q1 2022 | $183,000 | +40.8% | 6,119 | +9.5% | 0.00% | – |
Q4 2021 | $130,000 | -25.7% | 5,588 | 0.0% | 0.00% | – |
Q3 2021 | $175,000 | +94.4% | 5,588 | +117.8% | 0.00% | – |
Q2 2021 | $90,000 | -10.0% | 2,566 | -9.4% | 0.00% | – |
Q1 2021 | $100,000 | 0.0% | 2,832 | +5.6% | 0.00% | – |
Q4 2020 | $100,000 | +100.0% | 2,683 | +80.1% | 0.00% | – |
Q3 2020 | $50,000 | -5.7% | 1,490 | -25.5% | 0.00% | – |
Q2 2020 | $53,000 | +55.9% | 2,000 | -3.0% | 0.00% | – |
Q1 2020 | $34,000 | -43.3% | 2,061 | -12.8% | 0.00% | – |
Q4 2019 | $60,000 | +53.8% | 2,364 | +21.7% | 0.00% | – |
Q3 2019 | $39,000 | -26.4% | 1,943 | +19.0% | 0.00% | – |
Q2 2019 | $53,000 | 0.0% | 1,633 | 0.0% | 0.00% | – |
Q1 2019 | $53,000 | +60.6% | 1,633 | +20.2% | 0.00% | – |
Q4 2018 | $33,000 | -26.7% | 1,359 | 0.0% | 0.00% | – |
Q3 2018 | $45,000 | -6.2% | 1,359 | 0.0% | 0.00% | – |
Q2 2018 | $48,000 | – | 1,359 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
PA Capital LLC | 14,692 | $360,000 | 0.38% |
Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |